The nation of Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to the United States' demand for sensitive data.
This move was revealed following a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
A government representative later stated that the United States was requesting biological samples for scientific study and profit but refused to guarantee the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to reach a agreement suitable to all parties so the country's critical HIV programme can continue.
Broader Context
This development follows a comparable situation in neighbouring Kenya, where a court halted a similar health funding agreement after concerns were raised about the safety of citizens' health data.
After resuming office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance openness and responsibility.
As per reports, 16 African countries have to date signed these new health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Effectively, our nation would supply the raw materials for medical research without any certainty that the end products would be available to our citizens if a future disease outbreak emerge."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of bilateral deals were disrupting frameworks previously established via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage future pandemics.
"This mechanism is designed to ensure that when a country provides its samples, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the capability to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage ongoing discussions with our US partners on how subsequent co-operation might be arranged in a manner that honours the independence and dignity of both nations."
Health Experts Reaction
Medical experts stated it recognised the official position, but urged that negotiations should continue considering much of the nation's HIV programmes were funded by external financing.
"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group said.
The situation highlights the complex challenges between accepting crucial international aid and protecting a country's data in an ever more interconnected world.